Menu
/REGISTER
Montecito
Pac Premier
Loading...
You are here:  Home  >  'biosimilars'  -  Page 2
Latest

Amgen shares top $100 as fears fade over biosimilars

By   /  Friday, April 5th, 2013  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen shares top $100 as fears fade over biosimilars

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen power handoff comes at critical time

By   /  Friday, May 18th, 2012  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen power handoff comes at critical time

Incoming Amgen chief Robert Bradway takes the baton from longtime CEO Kevin Sharer as the world’s largest biotech company makes critical decisions about how it will compete with Big Pharma and biosimilars. Amgen, the Tri-Counties’ only blue-chip stock and the largest employer in the region with more than 6,000 employees, will install Bradway, a former Read More →

Read More →
Latest

Amgen looks for new life with Micromet

By   /  Friday, February 3rd, 2012  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen looks for new life with Micromet

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen to lay off 226 in Thousand Oaks

By   /  Wednesday, October 19th, 2011  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen to lay off 226 in Thousand Oaks

[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”19-04-2011″ enddate=”19-10-2011″ width=”300″ height=”245″] Thousand Oaks-based Amgen is laying off 226 people at its headquarters as part of a restructuring of its research operations. Worldwide, the R&D shakeup will affect 380 staff members, but the company’s headquarters are bearing the brunt of the cuts. The company said the layoffs are Read More →

Read More →
Latest

Amgen braces for biosimilars rules

By   /  Friday, October 7th, 2011  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen braces for biosimilars rules

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →